Phototherapy is associated with the decrease in serum globulin levels in neonatal hyperbilirubinemia

Zheng,Junwen; Wei,Cong; Zhao,Meng; Zhao,Dongchi

doi:10.3892/br.2018.1166

Phototherapy is associated with the decrease in serum globulin levels in neonatal hyperbilirubinemia

Authors:
- Junwen Zheng
- Cong Wei
- Meng Zhao
- Dongchi Zhao
View Affiliations

Affiliations: Department of Pediatrics and Neonatology, Children's Digital Health and Data Center, Zhongnan Hospital of Wuhan University, Wuhan, Hubei 430071, P.R. China
Published online on: November 9, 2018 https://doi.org/10.3892/br.2018.1166
Pages: 63-69

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Previous studies have indicated that phototherapy may be associated with childhood immune disorders in later life. The present study aimed to assess the effects of phototherapy as a risk factor in the decrease in serum globulin (GLB) levels during neonatal hyperbilirubinemia. A total of 430 full‑term infants aged between 1 and 28 days, diagnosed with neonatal hyperbilirubinemia, were enrolled in the present study. Neonates with intrauterine infection, genetic abnormalities and congenital diseases were excluded from the cohort. All neonates received single‑side phototherapy (halogen lamps for 12 h per day, for 3 days) and/or intravenous albumin (IVALB; 1 g/kg/day, for 2 days) and/or intravenous immunoglobulin (1 g/kg/day, for 2 days). Total serum bilirubin (TSB), albumin (ALB) and GLB levels were examined twice, on the first and fourth days of hospitalization. Neonatal TSB concentrations decreased from 299.6±83.9 to 163.6±57.6 µmol/l following 3 days of intensive treatment (P<0.001). Pearson correlative analysis indicated that TSB was significantly correlated to the GLB level (r=0.249; P<0.01), but not with ALB level. There was a significant decrease in GLB levels following phototherapy+IVALB (P<0.001). The GLB levels decreased to 2‑4 g/l (10‑20% compared with their baseline levels) and were markedly decreased in infants >16 days old compared with those in patients aged <16 days (P<0.001). The decreases in GLB levels observed were 21.3±4.1 to 18.5±4.2 g/l in the phototherapy group, and 23.0±3.9 to 16.6±4.5 g/l in the phototherapy+IVALB (P<0.001). The decrease in GLB levels was associated with age (95% confidence interval; ‑0.152, ‑0.016). The results demonstrated that phototherapy decreased serum GLB levels, particularly in infants aged >16 days, while additional IVALB treatment promoted the decrease, along with increased age.

View Figures

View References

1	American Academy of Pediatrics Subcommittee on Hyperbilirubinemia: Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics. 114:297–316. 2004. View Article : Google Scholar : PubMed/NCBI
2	Rennie J, Burman-Roy S and Murphy MS: Guideline Development Group: Neonatal jaundice: summary of NICE guidance. BMJ. 340:c24092010. View Article : Google Scholar : PubMed/NCBI
3	Gamaleldin R, Iskander I, Seoud I, Aboraya H, Aravkin A, Sampson PD and Wennberg RP: Risk factors for neurotoxicity in newborns with severe neonatal hyperbilirubinemia. Pediatrics. 128:e925–e931. 2011. View Article : Google Scholar : PubMed/NCBI
4	Hosono S, Ohno T, Kimoto H, Nagoshi R, Shimizu M and Nozawa M: Effects of albumin infusion therapy on total and unbound bilirubin values in term infants with intensive phototherapy. Pediatr Int. 43:8–11. 2001. View Article : Google Scholar : PubMed/NCBI
5	Huizing K, Røislien J and Hansen T: Intravenous immune globulin reduces the need for exchange transfusions in Rhesus and AB0 incompatibility. Acta Paediatr. 97:1362–1365. 2008. View Article : Google Scholar : PubMed/NCBI
6	Hosono S, Ohno T, Kimoto H, Nagoshi R, Shimizu M, Nozawa M and Harada K: Follow-up study of auditory brainstem responses in infants with high unbound bilirubin levels treated with albumin infusion therapy. Pediatr Int. 44:488–492. 2002. View Article : Google Scholar : PubMed/NCBI
7	Ahlfors CE and Wennberg RP: Bilirubin-albumin binding and neonatal jaundice. Semin Perinatol. 28:334–339. 2004. View Article : Google Scholar : PubMed/NCBI
8	Yokota T, Morioka I, Kodera T, Morisawa T, Sato I, Kawano S, Koda T, Matsuo K, Fujioka K, Morikawa S, et al: Novel treatment strategy for Japanese newborns with high serum unbound bilirubin. Pediatr Int. 55:54–59. 2013. View Article : Google Scholar : PubMed/NCBI
9	Xiong T, Chen H and Mu D: Effect of pre-exchange albumin infusion on neonatal hyperbilirubinaemia and long-term developmental outcomes. Cochrane Database of Systematic Reviews. (2): Art. no. CD011001. 2014.
10	Khera S and Gupta R: Incidence of thrombocytopenia following phototherapy in hyperbilirubinemic neonates. Med J Armed Forces India. 67:329–332. 2011. View Article : Google Scholar : PubMed/NCBI
11	Huang L, Bao Y, Xu Z, Lei X, Chen Y, Zhang Y and Zhang J: Neonatal bilirubin levels and childhood asthma in the US Collaborative Perinatal Project, 1959–1965. Am J Epidemiol. 178:1691–1697. 2013. View Article : Google Scholar : PubMed/NCBI
12	Sun HL, Lue KH and Ku MS: Neonatal jaundice is a risk factor for childhood allergic rhinitis: A retrospective cohort study. Am J Rhinol Allergy. 27:192–196. 2013. View Article : Google Scholar : PubMed/NCBI
13	Abourazzak S, Bouharrou A and Hida M: Jaundice and urinary tract infection in neonates: Simple coincidence or real consequence? Arch Pediatr. 20:974–978. 2013.(In French). View Article : Google Scholar : PubMed/NCBI
14	Chang HY, Cheng KS, Liu YP, Hung HF and Fu HW: Neonatal infected subgaleal hematoma: an unusual complication of early-onset E. coli sepsis. Pediatr Neonatol. 56:126–128. 2013. View Article : Google Scholar : PubMed/NCBI
15	Andersen JT, Dalhus B, Cameron J, Daba MB, Plumridge A, Evans L, Brennan SO, Gunnarsen KS, Bjørås M, Sleep D, et al: Structure-based mutagenesis reveals the albumin-binding site of the neonatal Fc receptor. Nat Commun. 3:610. 2012. View Article : Google Scholar : PubMed/NCBI
16	Maisels MJ and McDonagh AF: Phototherapy for neonatal jaundice. N Engl J Med. 358:920–928. 2008. View Article : Google Scholar : PubMed/NCBI
17	Hyvarinen M, Zeltzer P, Oh W and Stiehm ER: Influence of gestational age on serum levels of alpha-1 fetoprotein, IgG globulin, and albumin in newborn infants. J Pediatr. 82:430–437. 1973. View Article : Google Scholar : PubMed/NCBI
18	Salimonu LS, Ladipo OA, Adeniran SO and Osukoya BO: Serum immunoglobulin levels in normal, premature and postmature newborns and their mothers. Int J Gynaecol Obstet. 16:119–123. 1978–1979. View Article : Google Scholar
19	Ballow M, Cates KL, Rowe JC, Goetz C and Desbonnet C: Development of the immune system in very low birth weight (less than 1500 g) premature infants: Concentrations of plasma immunoglobulins and patterns of infections. Pediatr Res. 20:899–904. 1986. View Article : Google Scholar : PubMed/NCBI
20	Drossou V, Kanakoudi F, Diamanti E, Tzimouli V, Konstantinidis T, Germenis A, Kremenopoulos G and Katsougiannopoulos V: Concentrations of main serum opsonins in early infancy. Arch Dis Child Fetal Neonatal Ed. 72:F172–F175. 1995. View Article : Google Scholar : PubMed/NCBI
21	Keller MA and Stiehm ER: Passive immunity in prevention and treatment of infectious diseases. Clin Microbiol Rev. 13:602–614. 2000. View Article : Google Scholar : PubMed/NCBI
22	Jafarzadeh M: mohammadzadeh A. Should urine culture be considered in the hyperbilirubinemia workup of a neonate. JCCM. 4:136–138. 2009.
23	Shahian M, Rashtian P and Kalani M: Unexplained neonatal jaundice as an early diagnostic sign of urinary tract infection. Int J Infect Dis. 16:e487–e490. 2012. View Article : Google Scholar : PubMed/NCBI
24	Apaydin K, Ermis B, Arasli M, Tekin I and Ankarali H: Cytokines in human milk and late-onset breast milk jaundice. Pediatr Int. 54:801–805. 2012. View Article : Google Scholar : PubMed/NCBI
25	Eyada IK, El Saie AL, Ibrahem GA and Riad NM: Effect of phototherapy on B and T lymphocytes in Egyptian infants suffering from neonatal jaundice. Allergol Immunopathol (Madr). 45:290–296. 2017. View Article : Google Scholar : PubMed/NCBI
26	Liu P, Li L, Fan P, Zheng J and Zhao D: High-dose of intravenous immunoglobulin modulates immune tolerance in premature infants. BMC Pediatr. 18:742018. View Article : Google Scholar : PubMed/NCBI
27	Chang RJ, Chou HC, Chang YH, Chen MH, Chen CY, Hsieh WS and Tsao PN: Weight loss percentage prediction of subsequent neonatal hyperbilirubinemia in exclusively breastfed neonates. Pediatr Neonatol. 53:41–44. 2012. View Article : Google Scholar : PubMed/NCBI
28	El Sakka A, Imam SS, El Barbary M and Ibrahium W: Does Type of Infant Feeding Affect Phototherapy for Neonatal Hyperbilirubinemia? SAGE J. 4:334–339. 2012.
29	Cuperus FJ, Schreuder AB, van Imhoff DE, Vitek L, Vanikova J, Konickova R, Ahlfors CE, Hulzebos CV and Verkade HJ: Beyond plasma bilirubin: The effects of phototherapy and albumin on brain bilirubin levels in Gunn rats. J Hepatol. 58:134–140. 2013. View Article : Google Scholar : PubMed/NCBI
30	Cohen RS, Wong RJ and Stevenson DK: Understanding neonatal jaundice: A perspective on causation. Pediatr Neonatol. 51:143–148. 2010. View Article : Google Scholar : PubMed/NCBI